2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL;Lancellotti P;Rodriguez Muñoz D;Aboyans V;Asteggiano R;Galderisi M;Habib G;Lenihan DJ;Lip GY;Lyon AR;Lopez Fernandez T;Mohty D;Piepoli MF;Tamargo J;Torbicki A;Suter TM;Zamorano JL;Aboyans V;Achenbach S;Agewall S;Badimon L;Barón-Esquivias G;Baumgartner H;Bax JJ;Bueno H;Carerj S;Dean V;Erol Ç;Fitzsimons D;Gaemperli O;Kirchhof P;Kolh P;Lancellotti P;Lip GY;Nihoyannopoulos P;Piepoli MF;Ponikowski P;Roffi M;Torbicki A;Vaz Carneiro A;Windecker S;Achenbach S;Minotti G;Agewall S;Badimon L;Bueno H;Cardinale D;Carerj S;Curigliano G;de Azambuja E;Dent S;Erol C;Ewer MS;Farmakis D;Fietkau R;Fitzsimons D;Gaemperli O;Kirchhof P;Kohl P;McGale P;Ponikowski P;Ringwald J;Roffi M;Schulz-Menger J;Stebbing J;Steiner RK;Szmit S;Vaz Carneiro A;Windecker S

2017-01-01